Dr Reddy’s gets DCGI nod for oesophageal cancer drug Zytorvi
Dr Reddy's Laboratories has received Drugs Controller General of India (DCGI) approval for Zytorvi (toripalimab) in combination with cisplatin and paclitaxel for the first-line treatment of adult patients with unresectable advanced, recurrent,…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.